Dusan Stefoski - Concepedia

Author

Dusan Stefoski

Rush University Medical Center

Also Known As

D Stefoski, D. Stefoski, Dusan Stefoski

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center Biogen (United States)Queen Mary University of London Charles University Ruhr University Bochum

About

Dusan Stefoski is an author at Rush University Medical Center specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	2.6K
2	Social Sciences	4	4	237
3	Health Sciences	2	2	929
4	Cell Biology	2	2	125
5	Allergy	1	1	43

Dusan Stefoski

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Ludwig Kappos, Amit Bar‐Or, Bruce Cree, The Lancet Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological Monitoring	2018	896
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study Eva Havrdová, Steven Galetta, Michael Hutchinson, The Lancet Neurology RheumatologyRadiological Disease ActivitySystemic SclerodermaMedicineImmunology	2009	470
Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument David Cella, Kelly K. Dineen, B. G. W. Arnason, Neurology	1996	404
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial Ralf Gold, Gavin Giovannoni, Krzysztof Selmaj, The Lancet Relapsing-remitting Multiple SclerosisClinical TrialsTreatment OptionPlacebo-controlled TrialPharmacotherapy	2013	285
Treatment of Autoimmune Disease by Intense Immunosuppressive Conditioning and Autologous Hematopoietic Stem Cell Transplantation Richard K. Burt, Ann Traynor, Richard M. Pope, Blood	1998	211
Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in patients with high disability scores Richard K. Burt, Bruce A. Cohen, Eric J. Russell, Blood	2003	206
Orally administered 4‐aminopyridine improves clinical signs in multiple sclerosis Floyd A. Davis, Dusan Stefoski, Jean Rush Annals of Neurology Neurological DisorderLactose Placebo CapsulesPharmacotherapySocial SciencesNeurological Functioning	1990	179
4‐Aminopyridine improves clinical signs in multiple sclerosis Dusan Stefoski, Floyd A. Davis, MARY M. FAUT, Annals of Neurology	1987	158
Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used Yvonne Loh, Yu Oyama, Laisvyde Statkute, Blood	2006	146
Freedom from disease activity in multiple sclerosis Eva Havrdová, Steven Galetta, Dusan Stefoski Neurology	2010	138

Page 1